Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel L Graham

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Nature Medicine|November 13, 2012
A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal diseaseRachel L Graham, Michelle M Becker, Lance D Eckerle, et al.
Journal of Virology|February 26, 2005
Single-amino-acid substitutions in open reading frame (ORF) 1b-nsp14 and ORF 2a proteins of the coronavirus mouse hepatitis virus are attenuating in miceSteven M Sperry, Lubna Kazi, Rachel L Graham, et al.
Journal of Virology|May 14, 2004
Cleavage between replicase proteins p28 and p65 of mouse hepatitis virus is not required for virus replicationMark R Denison, Boyd Yount, Sarah M Brockway, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
Expanded subgenomic mRNA transcriptome and coding capacity of a nidovirusHan Di, Joseph C Madden, Esther K Morantz, et al.
Journal of Virology|October 26, 2018
Human Norovirus Epitope D Plasticity Allows Escape from Antibody Immunity without Loss of Capacity for Binding Cellular LigandsLisa C Lindesmith, Paul D Brewer-Jensen, Michael L Mallory, et al.
Biorxiv : the Preprint Server for Biology|June 27, 2020
Comparative analysis of coronavirus genomic RNA structure reveals conservation in SARS-like coronavirusesWes Sanders, Ethan J Fritch, Emily A Madden, et al.
Mbio|May 2, 2013
Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirusLaurence Josset, Vineet D Menachery, Lisa E Gralinski, et al.
Journal of Virology|April 9, 2024
Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19Adrianus C M Boon, Traci L Bricker, Ethan J Fritch, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Efficacy of Host Cell Serine Protease Inhibitor MM3122 against SARS-CoV-2 for Treatment and Prevention of COVID-19Adrianus C M Boon, Traci L Bricker, Ethan J Fritch, et al.
Antiviral Research|June 25, 2019
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymeraseAriane J Brown, John J Won, Rachel L Graham, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Nature Medicine|November 13, 2012
A live, impaired-fidelity coronavirus vaccine protects in an aged, immunocompromised mouse model of lethal diseaseRachel L Graham, Michelle M Becker, Lance D Eckerle, et al.
Journal of Virology|February 26, 2005
Single-amino-acid substitutions in open reading frame (ORF) 1b-nsp14 and ORF 2a proteins of the coronavirus mouse hepatitis virus are attenuating in miceSteven M Sperry, Lubna Kazi, Rachel L Graham, et al.
Journal of Virology|May 14, 2004
Cleavage between replicase proteins p28 and p65 of mouse hepatitis virus is not required for virus replicationMark R Denison, Boyd Yount, Sarah M Brockway, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2017
Expanded subgenomic mRNA transcriptome and coding capacity of a nidovirusHan Di, Joseph C Madden, Esther K Morantz, et al.
Journal of Virology|October 26, 2018
Human Norovirus Epitope D Plasticity Allows Escape from Antibody Immunity without Loss of Capacity for Binding Cellular LigandsLisa C Lindesmith, Paul D Brewer-Jensen, Michael L Mallory, et al.
Biorxiv : the Preprint Server for Biology|June 27, 2020
Comparative analysis of coronavirus genomic RNA structure reveals conservation in SARS-like coronavirusesWes Sanders, Ethan J Fritch, Emily A Madden, et al.
Mbio|May 2, 2013
Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirusLaurence Josset, Vineet D Menachery, Lisa E Gralinski, et al.
Journal of Virology|April 9, 2024
Efficacy of host cell serine protease inhibitor MM3122 against SARS-CoV-2 for treatment and prevention of COVID-19Adrianus C M Boon, Traci L Bricker, Ethan J Fritch, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Efficacy of Host Cell Serine Protease Inhibitor MM3122 against SARS-CoV-2 for Treatment and Prevention of COVID-19Adrianus C M Boon, Traci L Bricker, Ethan J Fritch, et al.
Antiviral Research|June 25, 2019
Broad spectrum antiviral remdesivir inhibits human endemic and zoonotic deltacoronaviruses with a highly divergent RNA dependent RNA polymeraseAriane J Brown, John J Won, Rachel L Graham, et al.
Pageof 7